Dr Raoul Reulen PhD

Dr Raoul Reulen

Institute of Applied Health Research
Senior Lecturer & Head of Education

Contact details

Centre for Childhood Cancer Survivor Studies
Institute of Applied Health Research
Robert Aitken Building
University of Birmingham
Birmingham, B15 2TY

Raoul Reulen is a Senior Lecturer & NIHR Fellow at the Centre for Childhood Cancer Survivor Studies.

Raoul’s primary research interest is cancer survivorship, particularly long-term survival after childhood cancer. Raoul has co-authored over 25 publications. He has taught undergraduate and post-graduate courses in Epidemiology, cancer and medical statistics since 2005. His current research program focuses on setting up a large-scale cohort of 300,000 survivors of cancer in teenage and young adulthood.


  • PhD Cancer Epidemiology, University of Birmingham,  2009
  • MSc Epidemiology, Maastricht University, 2005
  • MSc Health Sciences, Maastricht University, 2005


Teaching Programmes

Medicine and Surgery MBChB:

– Clinical Epidemiology (Year 1)
– Cancer Epidemiology (Year 1)
– Cancer (Year 2)
– Medical Statistics (Year 2)
– Epidemiological Methods (Year 3)

Public Health MPH/Diploma/Certificate:

- Advanced Applied Epidemiology module
- Epidemiology, Statistics and Health Information (ESHI)


– Supervised several MSc students

Postgraduate supervision

Dr Reulen is interested in supervising doctoral research on late physical effects in survivors of a cancer in childhood, teenage years or young adulthood.


Childhood Cancer Survivors Face Long-Term Mortality Risks


Recent publications


Byrne, J, Schmidtmann, I, Rashid, H, Hagberg, O, Bagnasco, F, Bardi, E, De Vathaire, F, Essiaf, S, Winther, JF, Frey, E, Gudmundsdottir, T, Haupt, R, Hawkins, MM, Jakab, Z, Jankovic, M, Kaatsch, P, Kremer, LCM, Kuehni, CE, Harila-Saari, A, Levitt, G, Reulen, R, Ronckers, CM, Maule, M, Skinner, R, Steliarova-Foucher, E, Terenziani, M, Zaletel, LZ, Hjorth, L, Garwicz, S & Grabow, D 2022, 'Impact of era of diagnosis on cause-specific late mortality among 77 423 five-year European survivors of childhood and adolescent cancer: the PanCareSurFup consortium', International Journal of Cancer, vol. 150, no. 3, pp. 406-419. https://doi.org/10.1002/ijc.33817

Wang, Y, Reulen, RC, Kremer, LCM, de Vathaire, F, Haupt, R, Zadravec Zaletel, L, Bagnasco, F, Demoor-Goldschmidt, C, van Dorp, WJ, Haddy, N, Hjorth, L, Jakab, Z, Kuehni, CE, Lähteenmäki, PM, van der Pal, HJH, Sacerdote, C, Skinner, R, Terenziani, M, Wesenberg, F, Winther, JF, van Leeuwen, FE, Hawkins, MM, Teepen, JC, van Dalen, EC & Ronckers, CM 2022, 'Male breast cancer after childhood cancer: systematic review and analyses in the PanCareSurFup cohort', European Journal of Cancer, vol. 165, pp. 27-47. https://doi.org/10.1016/j.ejca.2022.01.001

de Baat, EC, Feijen, EAM, Reulen, RC, Allodji, RS, Bagnasco, F, Bardi, E, Belle, FN, Byrne, J, van Dalen, EC, Debiche, G, Diallo, I, Grabow, D, Hjorth, L, Jankovic, M, Kuehni, CE, Levitt, G, Llanas, D, Loonen, J, Zaletel, LZ, Maule, MM, Miligi, L, van der Pal, HJH, Ronckers, CM, Sacerdote, C, Skinner, R, Jakab, Z, Veres, C, Haddy, N, Winter, DL, de Vathaire, F, Hawkins, MM & Kremer, LCM 2022, 'Risk factors for heart failure among pan-European childhood cancer survivors: a PanCareSurFup and ProCardio cohort and nested case-control study', Journal of Clinical Oncology . https://doi.org/10.1200/JCO.21.02944

King, D, Chandan, J, Thomas, T, Denniston, A, Braithwaite, T, Nirantharakumar, K, Reulen, R, Adderley, N & Trudgill, N 2022, 'Risk of a subsequent diagnosis of inflammatory bowel disease in subjects with ophthalmic disorders associated with inflammatory bowel disease: a retrospective cohort analysis of UK primary care data', BMJ open, vol. 12, no. 5, e052833. https://doi.org/10.1136/bmjopen-2021-052833

Sunguc, C, Hawkins, M, Winter, DL, Dudley, IM, Heymer, EJ, Teepen, JC, Allodji, RS, Belle, FN, Bagnasco, F, Byrne, J, Bárdi, E, Ronckers, CM, Haddy, N, Gudmundsdottir, T, Garwicz, S, Jankovic, M, Pal, HJHVD, Mazić, MČ, Schindera, C, Grabow, D, Maule, MM, Kaatsch, P, Fresneau, B, Michel, G, Skinner, R, Wiebe, T, Sacerdote, C, Jakab, Z, Gunnes, MW, Terenziani, M, Winther, JF, Lähteenmäki, PM, Zaletel, LZ, Kuehni, CE, Kremer, LC, Haupt, R, Vathaire, FD, Hjorth, L & Reulen, R 2022, 'Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study', British Journal of Cancer. https://doi.org/10.1038/s41416-022-02016-w

King, D, Coupland, B, Dosanjh, A, Cole, A, Ward, S, Reulen, R, Adderley, N, Patel, P & Trudgill, N 2022, 'The risk of subsequent surgery following bowel resection for Crohn’s disease in a national cohort of 19,207 patients', Colorectal Disease. https://doi.org/10.1111/codi.16331

Cesen Mazic, M, Reulen, RC, Jazbec, J & Zadravec Zaletel, L 2022, 'Trends in treatment of childhood cancer and subsequent primary neoplasm risk', Radiology and oncology, vol. 56, no. 3, pp. 380-389. https://doi.org/10.2478/raon-2022-0027

Fidler-Benaoudia, MM, Oeffinger, KC, Yasui, Y, Robison, LL, Winter, DL, Reulen, RC, Leisenring, WM, Chen, Y, Armstrong, GT & Hawkins, MM 2021, 'A comparison of late mortality among survivors of childhood cancer in the United States and United Kingdom', Journal of the National Cancer Institute, vol. 113, no. 5, pp. 562-571. https://doi.org/10.1093/jnci/djaa151

Sharif, A, Peracha, J, Winter, D, Reulen, R & Hawkins, M 2021, 'Exploring the Epidemiology of Cancer after Solid Organ Transplantation (EpCOT): an observational cohort study', BMJ open, vol. 11, no. 4, e043731. https://doi.org/10.1136/bmjopen-2020-043731

Reulen, RC, Guha, J, Bright, CJ, Henson, KE, Feltbower, RG, Hall, M, Kelly, JS, Winter, DL, Kwok‐williams, M, Skinner, R, Cutter, DJ, Frobisher, C & Hawkins, MM 2021, 'Risk of cerebrovascular disease among 13,457 five-year survivors of childhood cancer: a population based cohort study', International Journal of Cancer, vol. 148, no. 3, pp. 572-583. https://doi.org/10.1002/ijc.33218

King, D, Chandan, JS, Thomas, T, Nirantharakumar, K, Reulen, R, Adderley, N & Trudgill, N 2021, 'The risk of later diagnosis of inflammatory bowel disease in patients with dermatological disorders associated with inflammatory bowel disease', Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaa344

King, D, Coupland, B, Dosanjh, A, Cole, A, Adderley, N, Reulen, R, Patel, P & Trudgill, N 2021, 'The risk of later surgery at the anastomotic site following right hemicolectomy for Crohn’s disease in a national cohort of 12 230 patients', Alimentary Pharmacology & Therapeutics, vol. 53, no. 1, pp. 114-127. https://doi.org/10.1111/apt.16114

King, D, Reulen, R, Thomas, T, Chandan, J, Thayakaran, R, Subramanian, A, Gokhale, K, Bhala, N, Nirantharakumar, K, Adderley, N & Trudgill, N 2020, 'Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018', Alimentary Pharmacology & Therapeutics, vol. 51, no. 10, pp. 922-934. https://doi.org/10.1111/apt.15701

Jochems, S, Reulen, R, Van Osch, F, Witlox, WJA, Goossens, ME, Brinkman, M, Giles, GG, Milne, RL, van den Brandt, PA, White, E, Weiderpass, E, Huybrechts, I, Hémon, B, Agudo, A, Bueno-de-Mesquita, B, Cheng, KK, van Schooten, FJ, Bryan, R, Wesselius, A & Zeegers, M 2020, 'Fruit consumption and the risk of bladder cancer: a pooled analysis by the BLadder cancer Epidemiology and Nutritional Determinants study', International Journal of Cancer, vol. 147, no. 8, pp. 2091-2100. https://doi.org/10.1002/ijc.33008

Review article

Bowers, DC, Verbruggen, LC, Kremer, LCM, Hudson, MM, Skinner, R, Constine, LS, Sabin, ND, Bhangoo, R, Haupt, R, Hawkins, MM, Jenkinson, H, Khan, RB, Klimo, P, Pretorius, P, Ng, A, Reulen, RC, Ronckers, CM, Sadighi, Z, Scheinemann, K, Schouten-van Meeteren, N, Sugden, E, Teepen, JC, Ullrich, NJ, Walter, A, Wallace, WH, Oeffinger, KC, Armstrong, GT, van der Pal, HJH & Mulder, RL 2021, 'Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group', The Lancet Oncology, vol. 22, no. 5, pp. e196-e206. https://doi.org/10.1016/S1470-2045(20)30688-4

View all publications in research portal